These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17201277)

  • 1. [The effects of mexicor on thrombocyte aggregation, blood viscosity, hemodynamics, and the clinical course of coronary artery disease].
    Kazantsev DN; Prolubshchikov VA; Sokolianskiĭ NV; Chernov SA
    Klin Med (Mosk); 2006; 84(10):59-62. PubMed ID: 17201277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The in-vitro effects of E5555, a protease-activated receptor (PAR)-1 antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery disease.
    Serebruany VL; Kogushi M; Dastros-Pitei D; Flather M; Bhatt DL
    Thromb Haemost; 2009 Jul; 102(1):111-9. PubMed ID: 19572075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Differentiated treatment of diabetics with an acute coronary syndrome].
    Hamm CW; Hamann A
    Dtsch Med Wochenschr; 2006 Nov; 131(47 Suppl 7):S208-10. PubMed ID: 17109250
    [No Abstract]   [Full Text] [Related]  

  • 4. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy.
    Cesari F; Marcucci R; Caporale R; Paniccia R; Romano E; Gensini GF; Abbate R; Gori AM
    Thromb Haemost; 2008 May; 99(5):930-5. PubMed ID: 18449424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of platelet reactivity on cardiovascular outcomes in patients with type 2 diabetes mellitus and coronary artery disease.
    Angiolillo DJ; Bernardo E; Sabaté M; Jimenez-Quevedo P; Costa MA; Palazuelos J; Hernández-Antolin R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Guzman LA; Bass TA; Macaya C; Fernandez-Ortiz A
    J Am Coll Cardiol; 2007 Oct; 50(16):1541-7. PubMed ID: 17936152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long-term use of blockers of the platelet ADP receptor in acute coronary syndromes.
    De Caterina R; Zimarino M
    Haematologica; 2001 Nov; 86(11 Suppl 2):25-7. PubMed ID: 11926769
    [No Abstract]   [Full Text] [Related]  

  • 8. Optical platelet aggregation versus thromboxane metabolites in healthy individuals and patients with stable coronary artery disease after low-dose aspirin administration.
    Hedegaard SS; Hvas AM; Grove EL; Refsgaard J; Rocca B; Daví G; Kristensen SD
    Thromb Res; 2009 May; 124(1):96-100. PubMed ID: 19215971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mean platelet volume and size distribution and their sensitivity to agonists in patients with coronary artery disease and congestive heart failure.
    Erne P; Wardle J; Sanders K; Lewis SM; Maseri A
    Thromb Haemost; 1988 Apr; 59(2):259-63. PubMed ID: 3388297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of aspirin dosing in non-ST-elevation acute coronary syndromes in the CRUSADE Quality Improvement Initiative.
    Tickoo S; Roe MT; Peterson ED; Milford-Beland S; Ohman EM; Gibler WB; Pollack CV; Cannon CP;
    Am J Cardiol; 2007 Jun; 99(11):1496-9. PubMed ID: 17531568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temporal effect of Guanxin No. 2 on cardiac function, blood viscosity and angiogenesis in rats after long-term occlusion of the left anterior descending coronary artery.
    Zeng X; He H; Yang J; Yang X; Wu L; Yu J; Li L
    J Ethnopharmacol; 2008 Aug; 118(3):485-94. PubMed ID: 18579111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral antiplatelet therapies have no effect on circulating levels of RANTES in patients with coronary artery disease.
    Bahrmann P; Sigusch HH; Surber R; Figulla HR
    Pharmazie; 2002 Dec; 57(12):863-4. PubMed ID: 12561256
    [No Abstract]   [Full Text] [Related]  

  • 13. Clopidogrel-mediated reduction of circulating tissue factor in patients with stable coronary artery disease.
    Stellbaum C; Willich T; Boltzen U; Ayral Y; Szotowski B; Piorkowski M; Schultheiss HP; Rauch U
    Eur J Haematol; 2007 Apr; 78(4):347-52. PubMed ID: 17331131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immature platelets in patients with acute coronary syndromes.
    Grove EL; Hvas AM; Kristensen SD
    Thromb Haemost; 2009 Jan; 101(1):151-6. PubMed ID: 19132202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of increased aspirin dose versus combined aspirin plus clopidogrel therapy in patients with diabetes mellitus and coronary heart disease and impaired antiplatelet response to low-dose aspirin.
    Duzenli MA; Ozdemir K; Aygul N; Soylu A; Tokac M
    Am J Cardiol; 2008 Aug; 102(4):396-400. PubMed ID: 18678294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Timing of death and myocardial infarction in patients with non-ST elevation acute coronary syndromes: insights from randomized clinical trials.
    Mehta RH; Greenbaum AB; Lokhnygina Y; Newby LK; Van De Werf F; Armstrong PW; Pieper KS; Califf RM; Granger CB; Harrington RA
    J Interv Cardiol; 2007 Oct; 20(5):299-306. PubMed ID: 17880325
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tirofiban optimizes platelet inhibition for immediate percutaneous coronary intervention in high-risk acute coronary syndromes.
    Ivandic BT; Kurz K; Keck F; Staritz P; Lehrke S; Katus HA; Giannitsis E
    Thromb Haemost; 2008 Oct; 100(4):648-54. PubMed ID: 18841288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Residual platelet activity is increased in clopidogrel- and ASA-treated patients with coronary stenting for acute coronary syndromes compared with stable coronary artery disease.
    Geisler T; Kapp M; Göhring-Frischholz K; Daub K; Dösch C; Bigalke B; Langer H; Herdeg C; Gawaz M
    Heart; 2008 Jun; 94(6):743-7. PubMed ID: 17567647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Editorial on "Residual platelet reactivity is an independent predictor of myocardial injury in acute myocardial infarction patients on antiaggregant therapy" by Marcucci et al.
    Geisler T; Gawaz M
    Thromb Haemost; 2007 Oct; 98(4):705-6. PubMed ID: 17938789
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.